RCM
HAE icon

Rutabaga Capital Management’s Haemonetics HAE Stock Holding History

Rutabaga Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-178,976
Closed -$10.4M – 51
2017
Q4 		$10.4M Sell
178,976
-47,100
-21% -$2.48M 2.39% 18
2017
Q3 		$10.1M Sell
226,076
-217,193
-49% -$9.02M 2.16% 17
2017
Q2 		$17.5M Sell
443,269
-50,150
-10% -$2.06M 3.27% 10
2017
Q1 		$20M Sell
493,419
-20,200
-4% -$789K 3.33% 4
2016
Q4 		$20.6M Sell
513,619
-4,868
-0.9% -$184K 3.54% 8
2016
Q3 		$18.8M Sell
518,487
-95,700
-16% -$3.29M 3.55% 2
2016
Q2 		$17.8M Buy
+614,187
New +$18.6M 3.32% 8

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Rutabaga Capital Management's HAE Position: Q1 2018 in Review

Rutabaga Capital Management sold out of Haemonetics (HAE) in Q1 2018, closing a stake of 178,976 shares — an estimated $10.4M sold.

Rutabaga Capital Management first reported a position in HAE in Q2 2016 and held it in 7 quarters. The position peaked at $20.6M in Q4 2016. 261 funds tracked by Wall St. Rank hold HAE as of Q1 2018.

  • Rutabaga Capital Management reported no remaining Haemonetics position as of Q1 2018 after selling out during the quarter.
  • Rutabaga Capital Management sold 178,976 Haemonetics shares in Q1 2018, an estimated $10.4M.
  • Rutabaga Capital Management first reported a position in Haemonetics in Q2 2016 and held it in 7 quarters.
  • Rutabaga Capital Management's Haemonetics position peaked at $20.6M in Q4 2016.
  • 261 funds tracked by Wall St. Rank held Haemonetics as of Q1 2018.

Based on Rutabaga Capital Management's 13F filing for Q1 2018, filed 26 Apr 2018.